Key result
Elevated baseline hs-CRP predicts ~12% higher AHRE risk in pacemaker patients with preserved EF.
Why the study?
It remains controversial whether inflammation is a cause or consequence of AF, prompting investigation into whether hs-CRP can predict subsequent AHREs.
Does baseline hs-CRP predict subsequent atrial high-rate episodes in patients with pacemakers and preserved ejection fraction?
Cohort (n=171)
Does baseline hs-CRP predict subsequent atrial high-rate episodes in patients with pacemakers and preserved ejection fraction?
Effect estimate: HR 1.121 (95% CI 1.015-1.238)
p-value: p=0.024
Elevated baseline hs-CRP independently predicts the development of atrial high-rate episodes in patients with pacemakers and preserved ejection fraction, suggesting a role for inflammation in AF pathogenesis.
May aid AHRE risk stratification in pacemaker patients; extends inflammation-AF observations but remains hypothesis-generating.
Atrial fibrillation (AF) is associated with morbidity and mortality. Modern pacemakers can detect atrial high-rate episodes (AHREs) as a surrogate for AF. It remains controversial whether inflammation is a cause or a consequence of AF. This study investigated whether the inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) can predict subsequent AHREs. This study gathered prospective data from patients with pacemakers and a left ventricle EF ≥ 50% between 2015 and 2019. The hs-CRP and other cardiac biomarkers at baseline and device-detected AHREs, defined as atrial rate ≥ 180 bpm and duration ≥ 6 min, were determined. Cox regression analysis was used to estimate the independent predictors for AHREs. A total of 171 consecutive patients were included. During the median follow-up of 614 days, 66 patients (39%) developed subsequent AHREs. In the univariate Cox regression analysis, sick sinus syndrome (p = 0.005), prior AF (p < 0.001), mitral A velocity (p = 0.008), and hs-CRP (p = 0.013) showed significant association with the increased risk of AHREs. In the multivariate Cox regression model, hs-CRP (HR = 1.121, 95% confidence interval = 1.015–1.238, p = 0.024) retained its significance. Our results suggest that elevated hs-CRP could predict subsequent AHREs and that inflammation could play a role in AF pathogenesis in patients with preserved EF.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2020) conducted a cohort in Patients with pacemakers and preserved ejection fraction (n=171). High-sensitivity C-reactive protein (hs-CRP) was evaluated on Subsequent atrial high-rate episodes (AHREs) (HR 1.121, 95% CI 1.015-1.238, p=0.024). Elevated baseline hs-CRP independently predicted subsequent atrial high-rate episodes in patients with pacemakers and preserved ejection fraction (HR 1.121; 95% CI 1.015-1.238; p=0.024).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: